Related Experiment Videos
Mechanisms underlying arterial fragility and the complications of atherosclerosis
1Department of Pathology, Wellington School of Medicine, New Zealand.
Insights
Atherosclerosis etiology must explain pathological complications like intimal tears and aneurysms, linked to arterial wall fatigue and fragility. These issues manifest clinically, often exacerbated by hypertension or hemodynamic factors.
Area of Science:
- Biomedical Engineering
- Cardiovascular Pathology
- Vascular Biology
Background:
- Atherosclerosis etiology requires explaining primary pathological complications such as intimal tears, ectasia, tortuosity, aneurysms, and stenoses.
- These complications involve destruction of arterial mural architecture and loss of tensile strength (fragility).
- Existing etiological hypotheses do not adequately explain these arterial complications or their association with bioengineering fatigue.
Purpose of the Study:
- To propose an etiological framework for atherosclerosis that incorporates the development and interrelation of primary pathological vascular complications.
- To elucidate the role of bioengineering fatigue in arterial wall destruction and loss of tensile strength.
- To explain the clinical manifestations of atherosclerosis, including ischemia, hemorrhage, and pressure effects, in relation to hypertension, arteriovenous shunts, and connective tissue disorders.
Main Methods:
- Review and synthesis of existing literature on atherosclerosis pathology, vascular mechanics, and clinical manifestations.
- Analysis of the interrelationship between structural arterial changes and functional deficits.
- Examination of experimental and iatrogenic induction of vascular complications through hemodynamic means.
Main Results:
- Pathological vascular complications are interrelated and stem from destruction of mural architecture and loss of tensile strength due to bioengineering fatigue.
- Clinical manifestations like ischemia and hemorrhage are frequently associated with hypertension, arteriovenous shunts, or connective tissue disorders.
- Hemodynamic factors can experimentally and iatrogenically produce these vascular complications, a phenomenon not explained by current etiological models.
Conclusions:
- A comprehensive etiology of atherosclerosis must account for bioengineering fatigue-induced arterial wall destruction and associated pathological complications.
- The proposed framework integrates structural, mechanical, and clinical aspects of atherosclerosis, offering a more complete explanation than current hypotheses.
- Understanding the role of bioengineering fatigue is crucial for explaining the development and clinical presentation of atherosclerosis and its complications.
Abstract:
The etiology of atherosclerosis must explain the development of primary pathological complications (intimal tears, ectasia, tortuosity, aneurysms and stenoses). They are interrelated and associated with destruction of mural architecture and concomitant loss of tensile strength (fragility) attributable to bioengineering fatigue. The complications become manifested clinically by ischemia, hemorrhage and pressure effects developing with greater frequency in association with hypertension, arteriovenous shunts or connective tissue disorders. Moreover they are produced experimentally and iatrogenically by hemodynamic means but are unexplained by other current etiological hypotheses.